NEW YORK (GenomeWeb News) – PerkinElmer today said that it has entered into a drug discovery research collaboration with Sangmyung University in Korea, which will use the firm's AequoScreen assay technology for G-protein coupled receptor research.

PerkinElmer said that the AequoScreen cell-based assays are used to detect GPCR activation and provide advantages over conventional fluorescence-based dyes, such as fewer false positives, simpler protocol, and increased assay windows.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.